We are The Machine Learning Immunology Company
Integration is at Our Epicenter
At Seismic Therapeutic™, we believe our unique approach to applying machine learning to biologics drug discovery will create positive change in the autoimmune landscape and the lives of patients.
PipelinePlatform
Hyper-Collaboration Fuels Our Focus
Just like our approach, we are a synthesis of many things. Keenly focused and spirited, yet curious and relentless – we are open to the possibilities of the new and the uncharted. We fully believe that our impact on the drug discovery paradigm directly correlates to our willingness to embrace inclusivity and collaboration.
See what’s happening at Seismic Therapeutic™ with our latest news and events.
April 10, 2025
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease
Read more
March 18, 2025
Seismic Therapeutic Forms Translational Medicine Advisory Board with Prominent Experts in Immunology, Rheumatology, Dermatology and Neurology
Read more
March 11, 2025
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-1117, a Novel Pan IgG Protease Therapy for Antibody-Mediated Diseases
Read more